Covid Report: Pfizer Selects Lead Coronavirus Drug; Gilead Updates Tests
Pfizer stock jumped Thursday after the pharma giant identified a potential coronavirus treatment and inked a deal with BioNTech for a vaccine. Gilead updated its remdesivir studies.